Endo Pharmaceuticals Solutions Reports Fourth Quarter And Full Year 2013 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MALVERN, Pa., Feb. 28, 2014 /PRNewswire/ --

-- Company expects to close Paladin Labs transaction on February 28, 2014.

-- Full year 2013 adjusted diluted EPS exceeds previously issued guidance by $0.04.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC